To view a copy of this license, visit About this article Cite this article Xie, N., Zhang, L., Gao, W
Resources for Semaglutide Users with Eye Health Concerns For the most current information on semaglutide and eye health, we recommend consulting: The American Academy of Ophthalmology website The FDAs drug safety communications Reputable diabetes and obesity management organizations To report adverse effects related to Ozempic or Wegovy, use the FDAs MedWatch program
The DMA said the findings were strong enough that there should be an investigation into whether or not NAION should be listed as a possible adverse event when taking Ozempic
A 52 weeks, controlled trial, investigated the efficacy of GLP-1RAs of liraglutide (1.2 and 1.8 mg/day) vs
How often should patients be monitored after starting GLP-1 therapy remotely